| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |